ArticlePediatric blood & cancer2013

Phase I trial of fenretinide delivered orally in a novel organized lipid complex in patients with relapsed/refractory neuroblastoma: a report from the New Approaches to Neuroblastoma Therapy (NANT) consortium.

Barry J Maurer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.